Potential value of ctDNA monitoring in metastatic HR + /HER2 − breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial

BACKGROUND: There is increasing interest in the use of liquid biopsies, but data on longitudinal analyses of circulating tumor DNA (ctDNA) remain relatively limited. Here, we report a longitudinal ctDNA analysis of MONALEESASIA, a phase Ib trial evaluating the efficacy and safety of ribociclib plus...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Joanne, Su, Fei, Joshi, Mukta, Masuda, Norikazu, Ishikawa, Takashi, Aruga, Tomoyuki, Zarate, Juan Pablo, Babbar, Naveen, Balbin, O. Alejandro, Yap, Yoon-Sim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426213/
https://www.ncbi.nlm.nih.gov/pubmed/37580773
http://dx.doi.org/10.1186/s12916-023-03017-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426213/
https://www.ncbi.nlm.nih.gov/pubmed/37580773
http://dx.doi.org/10.1186/s12916-023-03017-z

Ejemplares similares